This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Carmen Rubio Alarcón group

Carmen Rubio Alarcón - Foto

Carmen Rubio Alarcón

Ph.D. student

Personal details

Experience

In July 2019 I joined the group of prof. dr. Gerrit Meijer under the supervision of dr. Remond Fijneman as a PhD student. During this project, we will try to find prognostic and predictive biomarkers in non-metastatic colorectal cancer, focusing on the study of cell-free circulating tumor DNA (ctDNA). This research will be performed within the Prospective Dutch Colorectal Cancer (PLCRC) cohort, an observational cohort study in which all patients diagnosed with colorectal cancer in more than 50 participating hospitals in the Netherlands can be enrolled. My main interest is translational oncology, and trying to build bridges between fundamental research and clinics. Before joining the NKI, I obtained a Bachelor in "Biochemistry" (Universidad Autónoma of Madrid), followed by a master in "International Clinical Trials Management" (ESAME). After two years working as study coordinator of phase I oncology clinical trials (Hospital General Universitario Gregorio Marañón), I moved to the Netherlands, where I obtained my Master of Science degree in "Cancer, stem cells and developmental biology" (Utrecht University) before starting my current PhD.

 

 

Share this page